Načítá se...
Sustained response to onabotulinumtoxin A in patients with chronic migraine: real-life data
BACKGROUND: Treatment with onabotulinumtoxin A (BT-A) is safe and effective for chronic migraine (CM). Several studies assessed possible predictors of response to treatment with BT-A, but there is little knowledge on the frequency and predictors of sustained response. The aim of this study was to ev...
Uloženo v:
| Vydáno v: | J Headache Pain |
|---|---|
| Hlavní autoři: | , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer Milan
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7183653/ https://ncbi.nlm.nih.gov/pubmed/32334534 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s10194-020-01113-6 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|